Thirteen leukemic patients with disease refractory to conventional chemotherapy were treated with 1.0 to 7.5 g/m2 of Cytosine Arabinoside (Ara-C) over 29 drug cycles. Drug infusions were spaced at 12-hour intervals; a maximum of four doses was administered over 36 hours. After single dose tolerance
β¦ LIBER β¦
Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia
β Scribed by Lalit Kumar; V. Kochupillai; Harsch Dua
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 408 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
High dose cytosine arabinoside (HDARAC)
β
Seth A. Rudnick; Edwin C. Cadman; Robert L. Capizzi; Roland T. Skeel; Joseph R.
π
Article
π
1979
π
John Wiley and Sons
π
English
β 415 KB
π 2 views
High-dose cytosine arabinoside for acute
β
Dr. Guy Cantin; James K. Brennan
π
Article
π
1984
π
John Wiley and Sons
π
English
β 421 KB
π 2 views
Low-dose cytosine arabinoside treatment
β
Herve Tilly; Sylvie Castaigne; Dominique Bordessoule; Francois Sigaux; Marie-thΓ©
π
Article
π
1985
π
John Wiley and Sons
π
English
β 347 KB
π 2 views
Low-dose cytosine arabinoside in the mye
β
J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart
π
Article
π
1985
π
John Wiley and Sons
π
English
β 351 KB
π 1 views
Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre
Low-dose cytosine arabinoside for treati
β
Heiwa Kanamori; Dr. Atsuo Maruta; Hiroko Miyashita; Hiroshi Harano; Hitoshi Fuka
π
Article
π
1992
π
John Wiley and Sons
π
English
β 403 KB
Cytosine arabinoside in acute leukemia o
β
D. G. Traggis; A. Dohlwitz; L. Das; N. Jaffe; W. C. Moloney; T. C. Hall
π
Article
π
1971
π
John Wiley and Sons
π
English
β 304 KB
π 2 views